Quaker Chemical swings to $26.8M profit on 10.2% sales growth, launches $250M buyback

Filed July 30, 2026 · Period ending June 30, 2026 · Compared to 10-Q Jul 31, 2025 · ~1 min read

Key Changes

• high

  Net income swung to $26.8M ($1.55 diluted EPS) from a $66.6M loss a year ago, driven by 10.2% revenue growth to $532.5M and absence of last year's $88.8M EMEA goodwill impairment.

  MD&A: Results verify on EDGAR →
• high

  Board approved a new $250M share repurchase program, replacing the prior $150M authorization, with no expiration date.

  MD&A: Capital Allocation verify on EDGAR →
• high

  Refinanced credit facility in April 2026: revolver expanded to $800M, maturity extended to 2031, and new $400M interest rate swaps at 3.58% fixed rate.

  MD&A: Liquidity verify on EDGAR →